Error loading player: No playable sources found
EXECUTIVE FORUM: Case Study Report-Outs and Panel Discussion - Part 4
Date
September 21, 2020
Speakers
President & CEO, Lachman Consultant Services
Consumer Safety Officer, FDA/ORA
Vice President of Global Engineering, Catalent Pharma Solutions
Head of Operations Quality, Compliance and External Affairs, AstraZeneca
International Relations Specialist / Diplomat At FDA, FDA/OC
Head of Global Quality Investigations, Viatris
Caroline Rocks, CEng
Senior Program Manager, AbbVie, Inc.
Senior Pharmaceutical Quality Assessor, FDA/CDER/OPQ/OPF
Carmelo Rosa, PsyD
Director, Division of Drug Quality I, FDA/CDER/OC/OMQ
Related Products
Executive Forum - Trends in Supply Chain Visibility & Control - Part 1
Executive Forum - Trends in Supply Chain Visibility & Control - Part 1 | The Executive Forum, led by global regulators and industry leaders, is an interactive discussion forum for pharmaceutical executives…
Out-of-Specifications (OOS) Investigations
Out-of-Specifications (OOS) Investigations | Why are regulatory inspectors still finding problems in Out-of-Specifications (OOS) investigations? Discussion of real examples will help you and your company to understand the difference between root cause analysis and CAPA…
Regulatory and Industry Panel - Supply Chain, Quality, and Compliance Issues in the Wake of the Covid-19 Pandemic
Regulatory and Industry Panel - Supply Chain, Quality, and Compliance Issues in the Wake of the Covid-19 Pandemic | In this interactive panel discussion, multiple representatives from FDA, MHRA, and CDSCO and executive leadership from industry will discuss the myriad challenges that the COVID-19 pa…
Regulatory and Industry Panel
Regulatory and Industry Panel | MAINTAINING FULL TRANSPARENCY WITH REGULATORY AGENCIES
